Maravai LifeSciences Announces Appointment of New Director to the Board
July 20, 2023
SAN DIEGO -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Robert (“Chip”) Hance has stepped down from the Company’s Board of Directors (the “Board”) effective July 19, 2023, and that Dr. John DeFord has been appointed to [...]
QIAGEN expands range of digital PCR kits and services for the biopharma industry
July 20, 2023
New partnership with Niba Labs to offer customized digital PCR (dPCR) assay design services to biopharma customers Launch of CGT Viral Vector Lysis Kit enabling standardized workflow from cell lysates to absolute and precise quantification of viral titers Biopharmaceutical companies increasingly adopting dPCR technology for enhanced drug safety and efficacy in drug development process Venlo, [...]
July 20, 2023
Patent-pending bioprocess has the potential to produce tens of millions of quality-controlled organoids per batch SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider, continues industrializing biology with its organoid line expansion services to support next-generation drug discovery. The offering leverages proprietary bioreactor and bioprocess technology to scale up the production of [...]
Tecan’s Phase Separator™: advancing automation for liquid biopsy and biobanking
July 20, 2023
Männedorf, Switzerland – Tecan proudly unveils Phase Separator™, an innovative liquid separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders. Phase Separator [...]
Absolute Biotech Relaunches SCICONS™ dsRNA Antibodies and ELISA Kits
July 20, 2023
The gold standard in dsRNA detection now available to virology researchers worldwide Boston, MA. -- Absolute Biotech, a new company uniting multiple antibody-centric brands into a single organization specializing in antibody reagents, kits and services, today announced the reintroduction of SCICONS™ dsRNA antibodies. Originally developed in 1990, SCICONS antibodies have become the gold standard in [...]
July 20, 2023
Fontus’ easy-to-use software, optimized deck access, verified NGS protocols and reformatting capabilities simplify workflows and improve turnaround times Enables nearly any liquid handling application to be automated Revvity will showcase additional industry-leading diagnostic solutions at 2023 AACC WALTHAM, Mass. -- Revvity (NYSE: RVTY), today announced the launch of the Fontus™ Automated Liquid Handling Workstation, a next-generation liquid [...]
July 20, 2023
Platform strengthens Gilead’s Research’s data science capabilities to accelerate research pipeline of transformative therapies Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a licensing agreement with Gilead Sciences, Inc. to help the company leverage the power of multi-omics data in the discovery of life-changing therapeutics across multiple [...]
July 20, 2023
LONGMONT, Colo. - KromaTiD, a single-cell analysis life science tools company focused on the research, development and commercialization of products for the cell and gene therapy market, announced today the launch of over 300 centromere, telomere and gene probes for use in directional Genomic Hybridization (dGH) in-Site™ assays. KromaTiD dGH™ products and services are widely used [...]
Elemental Machines Announces Edward Seguine As New Chief Executive Officer
July 20, 2023
Leadership Transition Signals Deeper Commitment To Life Sciences Market CAMBRIDGE, Mass. – Elemental Machines (EM), the pioneering developer of the comprehensive Intelligent Operations Platform for life sciences, has appointed Ed Seguine as Chief Executive Officer. Sridhar Iyengar, PhD, founder and incumbent CEO, will remain actively involved day-to-day as Chief Innovation Officer, leading the development of new [...]
July 19, 2023
Traditional pharmacological mechanisms leave a significant part of the genome ‘undruggable’, due to the inability to induce or block their activity using agonists and antagonists. Thanks to the discovery of molecules capable of hijacking de ubiquitin-proteosome system like PROTACs (PROteolysis TArgetting Chimeras), the current druggable genome has expanded and this is now one of the hottest topics [...]

